EUVIMEDEUVIMED entdecken
Leserbrief

A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2

Yakun Sun, Rui Zheng, Deyu Li, Yitai Fang, Liangyan Zhang, Xiaolan Yang, Wenjing Yu, Yeqing Tu, Dan Lu, Tao Li, Deyan Luo, Hui Wang iD

Immunology · 2026

DOI: 10.1111/imm.70092 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Immunology, 2026. Verfasst von Yakun Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: COVID-19 Vaccines, SARS-CoV-2, COVID-19, Adjuvants, Immunologic. Die Arbeit nennt 8 Literaturangaben. Gefördert von: Establishment of Infection Models and Discovery of Targets for Highly Pathogenic Pathogens., Beijing Natural Science Foundation, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesSARS-CoV-2COVID-19Adjuvants, ImmunologicSpike Glycoprotein, CoronavirusAnimalsMiceAntibodies, ViralImmunoglobulin Fc FragmentsHumansImmunoglobulin GRecombinant Fusion ProteinsFemaleAntibodies, NeutralizingLungT-Lymphocytes

Substanzen

COVID-19 VaccinesAntibodies, ViralAdjuvants, ImmunologicSpike Glycoprotein, CoronavirusImmunoglobulin Fc FragmentsImmunoglobulin GRecombinant Fusion Proteinsspike protein, SARS-CoV-2Antibodies, Neutralizing

Autor:innen und Institutionen

  • State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.

ORCID-Profile: Hui Wang

Förderung

  • Establishment of Infection Models and Discovery of Targets for Highly Pathogenic Pathogens.
  • Beijing Natural Science Foundation
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Sun, Y., Zheng, R., Li, D., Fang, Y., Zhang, L., Yang, X., Yu, W., Tu, Y., Lu, D., Li, T., Luo, D., & Wang, H. (2026). A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2. Immunology. https://doi.org/10.1111/imm.70092

Vancouver

Sun Y, Zheng R, Li D, Fang Y, Zhang L, Yang X, et al. A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2. Immunology. 2026. doi:10.1111/imm.70092

BibTeX
@article{Sun2026,
  author = {Sun, Yakun and Zheng, Rui and Li, Deyu and Fang, Yitai and Zhang, Liangyan and Yang, Xiaolan and Yu, Wenjing and Tu, Yeqing and Lu, Dan and Li, Tao and Luo, Deyan and Wang, Hui},
  title = {A Novel Prophylaxis Strategy Using Ecotin as A Promising Adjuvant for Fc‐RBD Fusion Protein Vaccine of SARS ‐ CoV ‐2},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70092}
}
Kostenlos starten →